These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8133796

  • 1. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M, Pedrazzoni M, Pioli G, Butturini L, Ruys AH, Cortenraad MG.
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [Abstract] [Full Text] [Related]

  • 2. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L, Hopper JL, Larkins RG, Lichtenstein M, Buirski G, Wark JD.
    Osteoporos Int; 1997 Nov; 7(1):29-35. PubMed ID: 9102059
    [Abstract] [Full Text] [Related]

  • 3. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C, AgnusDei D, Gonnelli S, Nardi P.
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [Abstract] [Full Text] [Related]

  • 4. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, Weaver DS.
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [Abstract] [Full Text] [Related]

  • 5. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M, Saraf ML.
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS, Hassager C, Pødenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C.
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [Abstract] [Full Text] [Related]

  • 7. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C, Riis BJ, Pødenphant J, Christiansen C.
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [Abstract] [Full Text] [Related]

  • 8. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
    Hassager C, Jensen LT, Johansen JS, Riis BJ, Melkko J, Pødenphant J, Risteli L, Christiansen C, Risteli J.
    Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
    [Abstract] [Full Text] [Related]

  • 9. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP, Androulakis C, Magiasis B, Charalambaki Z, Tsakalakos N.
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [Abstract] [Full Text] [Related]

  • 10. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG, Nordin BE, Chatterton BE.
    Osteoporos Int; 1993 Dec; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract] [Full Text] [Related]

  • 11. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 Dec; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 12. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
    Birkenhäger JC, Erdtsieck RJ, Zeelenberg J, van Kuik C, van Veen LC, Birkenhäger-Frenkel DH, Luiken GP, Kooy PP, Gerritsma EJ, Mulder P.
    Bone Miner; 1992 Sep; 18(3):251-65. PubMed ID: 1392698
    [Abstract] [Full Text] [Related]

  • 13. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.
    Adami S, Fossaluzza V, Rossini M, Bertoldo F, Gatti D, Zamberlan N, Lo Cascio V.
    Bone Miner; 1991 Oct; 15(1):73-81. PubMed ID: 1747568
    [Abstract] [Full Text] [Related]

  • 14. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.
    Frisoli A, Chaves PH, Pinheiro MM, Szejnfeld VL.
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):648-53. PubMed ID: 15972619
    [Abstract] [Full Text] [Related]

  • 15. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P.
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [Abstract] [Full Text] [Related]

  • 16. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Sep; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 17. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
    Erdtsieck RJ, Pols HA, van Kuijk C, Birkenhäger-Frenkel DH, Zeelenberg J, Kooy PP, Mulder P, Birkenhäger JC.
    J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941
    [Abstract] [Full Text] [Related]

  • 18. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
    Aerssens J, Van Audekercke R, Geusens P, Schot LP, Osman AA, Dequeker J.
    Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
    [Abstract] [Full Text] [Related]

  • 19. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C.
    Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
    [Abstract] [Full Text] [Related]

  • 20. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
    Bolanca S, Korsić M, Dekanić D, Cvijetić S.
    Acta Med Croatica; 1998 Jan; 52(3):159-63. PubMed ID: 9818438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.